Literature DB >> 30346531

Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.

Sang Hyoung Park1,2, Satimai Aniwan1,3, W Scott Harmsen4, William J Tremaine1, Amy L Lightner5, William A Faubion1, Edward V Loftus1.   

Abstract

BACKGROUND: This study sought to re-estimate the cumulative incidence of perianal or rectovaginal fistulas and the associated proctectomy rate in the prebiologic era vs the biologic era using a population-based cohort of Crohn's disease (CD) patients.
METHODS: The medical records of 414 residents of Olmsted County, Minnesota, who were diagnosed with CD between 1970 and 2010 were reviewed. The cumulative incidence of perianal or rectovaginal fistulas from time of CD diagnosis and the cumulative rate of proctectomy from date of first perianal or rectovaginal fistula diagnosis were estimated using the Kaplan-Meier method.
RESULTS: Eighty-five patients (20.5%) diagnosed with CD between 1970 and 2010 had at least 1 perianal or rectovaginal fistula episode between January 1, 1970, and June 30, 2016. The cumulative incidence of perianal or rectovaginal fistulas was 18% after 10 years, 23% after 20 years, and 24% after 30-40 years from CD diagnosis. The cumulative incidence of perianal or rectovaginal fistulas was significantly lower in patients diagnosed in 1998 or after than in patients diagnosed before 1998 (P = 0.03, log-rank). Among 85 patients developing perianal or rectovaginal fistulas, 16 patients (18.8%) underwent proctectomy for the treatment of perianal or rectovaginal fistulas during follow-up.
CONCLUSIONS: In a population-based inception cohort of CD, one-fifth of patients were diagnosed with at least 1 perianal or rectovaginal fistula. The cumulative probability of perianal or rectovaginal fistulizing disease has decreased over time.
© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; natural history; perianal fistula; rectovaginal fistula

Mesh:

Year:  2019        PMID: 30346531      PMCID: PMC6505440          DOI: 10.1093/ibd/izy329

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  38 in total

1.  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Authors:  David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  Infliximab for the treatment of fistulas in patients with Crohn's disease.

Authors:  D H Present; P Rutgeerts; S Targan; S B Hanauer; L Mayer; R A van Hogezand; D K Podolsky; B E Sands; T Braakman; K L DeWoody; T F Schaible; S J van Deventer
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

3.  The clinical course of fistulating Crohn's disease.

Authors:  S J Bell; A B Williams; P Wiesel; K Wilkinson; R C G Cohen; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

4.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

5.  PERIANAL FISTULAE AS A COMPLICATION OF REGIONAL ILEITIS.

Authors:  A Penner; B B Crohn
Journal:  Ann Surg       Date:  1938-11       Impact factor: 12.969

6.  Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.

Authors:  L J Egan; W J Sandborn; W J Tremaine
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

7.  Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.

Authors:  Kevin W A Göttgens; Steven F G Jeuring; Rosel Sturkenboom; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Daisy M A E Jonkers; Laurents P S Stassen; Ad A M Masclee; Marieke J Pierik; Stéphanie O Breukink
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-05       Impact factor: 2.566

8.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

9.  Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study.

Authors:  Yong Beom Cho; Woo Yong Lee; Kyu Joo Park; Mihyung Kim; Hee-Won Yoo; Chang Sik Yu
Journal:  Cell Transplant       Date:  2012-09-21       Impact factor: 4.064

10.  Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

Authors:  William J Sandborn; Daniel H Present; Kim L Isaacs; Douglas C Wolf; Eugene Greenberg; Stephen B Hanauer; Brian G Feagan; Lloyd Mayer; Therese Johnson; Joseph Galanko; Christopher Martin; Robert S Sandler
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

View more
  19 in total

1.  Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.

Authors:  Mingming Zhu; Xitao Xu; Qi Feng; Zhe Cui; Tianrong Wang; Yunqi Yan; Zhihua Ran
Journal:  Dig Dis Sci       Date:  2020-06-10       Impact factor: 3.199

Review 2.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

3.  Cell-based therapy for Crohn's disease: time to consider optimization.

Authors:  Amy L Lightner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

Review 4.  The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: Combined Medical-Surgical Treatment in Complex Perianal Fistulas in CD.

Authors:  Jeroen Geldof; Nusrat Iqbal; Janindra Warusavitarne; Ailsa Hart
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

Review 5.  A Multi-Disciplinary Approach to Perianal Fistulizing Crohn's Disease.

Authors:  Jacob Wiseman; Tanya Chawla; Frederic Morin; Anthony de Buck van Overstraeten; Adam V Weizman
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

Review 6.  Rectovaginal Fistula in Crohn's Disease: When and How to Operate?

Authors:  Jeremy Meyer; Frédéric Ris; Miles Parkes; Justin Davies
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

7.  Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.

Authors:  Konstantinos Papamichael; Niels Vande Casteele; Jenny Jeyarajah; Vipul Jairath; Mark T Osterman; Adam S Cheifetz
Journal:  Am J Gastroenterol       Date:  2021-05-01       Impact factor: 12.045

8.  Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.

Authors:  Rahul S Dalal; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 7.290

9.  Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.

Authors:  Rahul S Dalal; Cheikh Njie; Jenna Marcus; Sanchit Gupta; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325

10.  Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn's Disease.

Authors:  Hejun Zhou; Xuehong Wang; Feihong Deng; Pianpian Xia; Zengrong Wu
Journal:  Int J Gen Med       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.